Ophir should provide some income which is good - they are on a cost plus arrangement and the biggest risk I saw previously was the development never got the final green light from Petronas
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025